MMedication Read More Here’s What Experts Say You Need If You’re On A GLP-1October 14, 2026 It’s no secret that the use of GLP-1 antagonists like Ozempic and Wegovy is more widespread than ever.…
MMedication Read More GLP-1 drugs can ‘reverse biologic aging’ by two to three yearsOctober 12, 2026 Weight loss drugs may do more than melt away pounds — they could melt away years. Pharmaceutical companies…
MMedication Read More GLP-1s linked to a gross side effect in nails: studyOctober 9, 2026 Ozempic and Mounjaro can cost an arm and a leg — and maybe a fingernail. A new study…
MMental health Read More Can GLP-1 drugs help stop compulsive shopping, gambling and other ways people throw away their money?October 8, 2026 A growing body of research suggests GLP-1 drugs can do more than just help people lose weight by…
MMedication Read More Weight-loss drug use surges as lawsuits and side-effect concerns growOctober 6, 2026 LAS VEGAS (FOX5) — New Gallup data shows 11% of U.S. adults are taking weight loss drugs such…
MMedication Read More Study finds sharp increase in GLP-1 use among children ages 8 to 11October 6, 2026 While it is still relatively rare for young children to be prescribed GLP-1 medications, researchers say their use…
MMedication Read More A New King of The GLP-1s Could Be Crowned – Cardiac WireOctober 5, 2026 A New King of The GLP-1s Could Be Crowned Cardiac WirePeople with Type 2 diabetes lost up to 60…
MMedication Read More Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 TrialOctober 4, 2026 An experimental weight-loss injection has helped people with obesity lose an average of up to 25 per cent…
MMedication Read More GLP-1 use skyrocketed 24x in a key demographicOctober 3, 2026 This year, the number of US adults on a GLP-1 medication for weight loss reached an astonishing 11%…
MMedication Read More New weight-loss drug targets belly fat and can give ‘flatter stomach’ in weeksOctober 2, 2026 Could a new drug that makes fat cells self-destruct be the next big GLP-1? CBL-514 targets fat cells,…
MMedication Read More #EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy – Endpoints NewsOctober 1, 2026 #EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy Endpoints NewsThe Next Frontier for Obesity Drugs Isn’t…
MMedication Read More Dad says he went permanently blind — in lawsuit against Ozempic makersSeptember 30, 2026 Edward Gillen, 59, woke up one May morning last year and noticed a speck in his eye. The…